Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology

Monitoring Your Goiter Over Time

At a Glance

For a benign, nontoxic goiter, follow-up is tailored to the ultrasound risk pattern and may include neck exams, TSH blood tests, and repeat ultrasound. Small measurement changes are common; significant growth or new symptoms may lead to further evaluation.

When you are diagnosed with a benign, nontoxic goiter that isn’t causing symptoms, your doctor will likely recommend active surveillance (often called “watch and wait”). This is not “doing nothing.” Instead, it is a proactive, risk-stratified plan to ensure that your thyroid remains stable and that no new concerns develop over time [1][2].

The Surveillance Schedule

There is no single “one-size-fits-all” schedule for thyroid monitoring. Follow-up depends on whether you have a diffuse goiter or distinct nodules, your ultrasound risk pattern, whether a biopsy was performed, and the specific clinical guidelines your doctor follows (such as ATA or ACR guidelines) [3][4].

  • Individualized Timing: Some very low-risk nodules require no routine repeat imaging at all. Higher-risk nodules may be checked 6 to 12 months after the initial diagnosis to establish stability [5].
  • Long-term Monitoring: If imaging shows no change, intervals between scans often stretch out over several years [5][6].
  • Comprehensive Review: Surveillance is not just about ultrasounds. Your follow-up visits should also include a clinical neck exam to check for physical changes and blood tests (like TSH) to ensure your thyroid continues to function normally [1].

Defining “Significant Growth”

One of the main reasons for follow-up scans is to check for nodule growth. However, small variations in measurements are normal and often due to slight differences in how the ultrasound probe was held [7][8]. To account for this, doctors use specific thresholds to define significant growth [9]:

  1. The 20/2 Rule: An increase of at least 20% in at least two different dimensions (length, width, or depth), with a minimum absolute increase of at least 2 mm [9][10].
  2. The 50% Rule: An increase in the total calculated volume of the nodule by 50% or more [10][9].

It is important to remember that growth alone is usually not a sign of cancer [9]. Most benign nodules grow slowly over many years. If your nodule reaches these thresholds, your doctor will look for new “suspicious” features on the ultrasound before deciding if a repeat FNA biopsy is necessary [11][12].

Managing “Scanxiety” and the Emotional Burden

Living with a goiter that requires long-term monitoring can cause a specific type of stress often called scanxiety [13].

To help manage the emotional impact of surveillance:

  • Request a Written Plan: Ask your doctor for a clear, written surveillance plan. It should include the date for your next review, your current TSH result, your nodule measurements, and what specific symptoms should prompt an earlier call [14].
  • Understand the Risks: Remind yourself that benign nodules rarely transform into cancer. When a malignancy is found later in surveillance, it is usually because it was a new lesion that developed or an area that was missed during initial sampling, not because a truly benign nodule spontaneously turned malignant [6].
  • Focus on Symptoms: Day-to-day, you don’t need to check your neck in the mirror. Instead, stay aware of your physical comfort. If you notice new, persistent trouble swallowing, a change in your voice, or breathlessness, contact your specialist for a review regardless of when your next scan is scheduled [1].

Common questions in this guide

How often will I need an ultrasound for a benign nontoxic goiter?
There is no single schedule for everyone. Very low-risk nodules may not need routine repeat imaging, while higher-risk nodules may be checked after 6 to 12 months; if the findings remain stable, the interval may extend to several years.
How do doctors decide whether a thyroid nodule has grown significantly?
Significant growth is usually defined as at least a 20% increase in two or more dimensions, with an absolute increase of at least 2 millimeters, or a 50% or greater increase in calculated volume. Small differences can result from how the ultrasound was performed and may not represent true growth.
Does a growing thyroid nodule automatically mean cancer or another biopsy?
No. Growth alone usually does not mean that a nodule is cancerous, because many benign nodules enlarge slowly over time. Your clinician will also look for new suspicious ultrasound features before deciding whether to repeat a fine-needle aspiration biopsy.
What happens at a routine follow-up visit for a nontoxic goiter?
Follow-up may include a neck examination, review of symptoms, thyroid blood tests such as TSH, and ultrasound when appropriate. The clinician compares current nodule measurements and ultrasound features with the baseline results.
Which new goiter symptoms mean I should call before my next scan?
Contact your clinician if you develop persistent trouble swallowing, a voice change, breathlessness, new neck pressure, or another noticeable change. These symptoms should be reviewed even if your next ultrasound is not yet due.
How can I cope with anxiety while my goiter is being monitored?
Ask for a written plan that lists your next review date, thyroid blood test results, nodule measurements, and symptoms that should prompt an earlier call. Knowing the plan and discussing worries with your care team can make long-term surveillance easier to manage.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the exact ultrasound-pattern risk (like ACR TI-RADS or ATA pattern) for my largest nodule at baseline?
  2. 2.Is my next ultrasound scheduled for 6, 12, or 24 months, and what factors determine that specific timing for me?
  3. 3.If my next scan shows growth, will we automatically repeat the biopsy, or will we look for new suspicious features first?
  4. 4.Who will be reviewing my follow-up scans—will it be the same radiology clinic to ensure the measurements are consistent?
  5. 5.If I feel new pressure or have trouble swallowing before my next scan, what is the process for getting an earlier evaluation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Long-Term Surveillance for Benign Thyroid Nodules.

    Macera M, Melcarne R, Grani G

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(1)):77-86 doi:10.1016/j.eprac.2025.07.021.

    PMID: 40769308
  2. 2

    Contemporary Thyroid Nodule Evaluation and Management.

    Grani G, Sponziello M, Pecce V, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(9)) doi:10.1210/clinem/dgaa322.

    PMID: 32491169
  3. 3

    Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice Types.

    Twining CL, Lupo MA, Tuttle RM

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(9)):833-840 doi:10.4158/EP-2018-0130.

    PMID: 30308136
  4. 4

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

    Gharib H, Papini E, Garber JR, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(5)):622-39 doi:10.4158/EP161208.GL.

    PMID: 27167915
  5. 5

    Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review.

    Chou R, Dana T, Mayson SE, et al.

    Thyroid : official journal of the American Thyroid Association 2023; (33(4)):420-427 doi:10.1089/thy.2022.0692.

    PMID: 36800900
  6. 6

    Malignancy rates in thyroid nodules: a long-term cohort study of 17,592 patients.

    Grussendorf M, Ruschenburg I, Brabant G

    European thyroid journal 2022; (11(4)).

    PMID: 35635802
  7. 7

    Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules.

    Choi YJ, Baek JH, Hong MJ, Lee JH

    Korean journal of radiology 2015; (16(3)):560-5 doi:10.3348/kjr.2015.16.3.560.

    PMID: 25995685
  8. 8

    Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarcinoma.

    Chung SR, Choi YJ, Lee SS, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):452-458 doi:10.1089/thy.2020.0317.

    PMID: 33287640
  9. 9

    The natural history of benign thyroid nodules.

    Durante C, Costante G, Lucisano G, et al.

    JAMA 2015; (313(9)):926-35 doi:10.1001/jama.2015.0956.

    PMID: 25734734
  10. 10

    Changes in the Volume and Diameter of Benign Thyroid Nodules: A 10-Year Follow-Up Study.

    Erdoğan MF, Bahçecioğlu AB, Avcı Merdin F, et al.

    Thyroid : official journal of the American Thyroid Association 2025; (35(1)):31-40 doi:10.1089/thy.2024.0405.

    PMID: 39692610
  11. 11

    Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules.

    Maino F, Bufano A, Dalmazio G, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):446-451 doi:10.1089/thy.2020.0351.

    PMID: 32718278
  12. 12

    Rapid thyroid nodule growth is not a marker for well-differentiated thyroid cancer.

    Falch C, Axt S, Scuffi B, et al.

    World journal of surgical oncology 2015; (13()):338 doi:10.1186/s12957-015-0752-x.

    PMID: 26684213
  13. 13

    Anxiety disorders in patients with thyroid nodules vs. thyroid cancer: a retrospective cohort study.

    Kornelius E, Lo SC, Huang CN, et al.

    Frontiers in endocrinology 2025; (16()):1539442 doi:10.3389/fendo.2025.1539442.

    PMID: 40235655
  14. 14

    Thyroid nodules: diagnosis and management.

    Grani G, Sponziello M, Filetti S, Durante C

    Nature reviews. Endocrinology 2024; (20(12)):715-728 doi:10.1038/s41574-024-01025-4.

    PMID: 39152228

This page explains follow-up for a benign, nontoxic goiter for informational purposes only and does not constitute medical advice. Your clinician should set your ultrasound schedule and interpret changes in your symptoms, TSH results, and nodule measurements.

Get notified when new evidence is published on nontoxic goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.